Safety Alert for Alere TestPack + Plus with OBC hCG Urine

According to Department of Health, this safety alert involved a device in Hong Kong that was produced by Alere.

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Safety alert
  • Date
    2016-07-27
  • Event Date Posted
    2016-07-27
  • Event Country
  • Event Source
    DH
  • Event Source URL
  • Notes / Alerts
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Extra notes in the data
    Medical Device Safety Alert
  • Reason
    Medical device safety alert: alere testpack + plus with obc hcg urine it has come to the attention of the medical device control office that several maternal and child health centres of the department of health have reported incidents of false negative results relating to testpack + plus with obc hcg urine pregnancy test kit manufactured by alere. the issues have been reported to the local supplier, zenith medical co. ltd. and investigation is underway. if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 27 july 2016.

Device

  • Model / Serial
  • Product Description
    Medical Device Safety Alert: Alere TestPack + Plus with OBC hCG Urine
  • Manufacturer

Manufacturer

  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    DH